Skip to main content
Springer logoLink to Springer
. 2020 Mar 6;63(5):1088–1089. doi: 10.1007/s00125-020-05118-3

Correction to: Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)

Pablo Aschner 1,, Juan J Gagliardino 2, Hasan Ilkova 3, Fernando Lavalle 4, Ambady Ramachandran 5, Jean Claude Mbanya 6,7, Marina Shestakova 8, Jean-Marc Chantelot 9, Juliana C N Chan 10
PMCID: PMC7645475  PMID: 32140743

Correction to: Diabetologia

10.1007/s00125-019-05078-3

The standard deviations for ‘last HbA1c measurement’ in mmol/mol were miscalculated in Table 1 of this paper. The corrected table is reproduced here. The changes do not affect the interpretation of any of the data or the overall messages of the paper.

Table 1.

Clinical profiles, care processes and self-monitoring in participants with type 2 diabetes at enrolment between 2005 and 2017

Characteristic Wave 1 (2005)
N = 9918
Wave 2 (2006)
N = 17,232
Wave 3 (2008)
N = 12,210
Wave 4 (2010)
N = 5343
Wave 5 (2011–12)
N = 9603
Wave 6 (2013–14)
N = 5479
Wave 7 (2016–17)
N = 6303
Age, years (SD) 58.1 (11.5) 58.2 (11.8) 57.7 (11.8) 58.4 (11.9) 57.6 (11.2) 57.3 (10.7) 57.2 (11.1)
Female sex, n (%) 5130 (51.9) 8736 (52.2) 6458 (54.1) 2882 (54.3) 5117 (53.3) 3048 (55.6) 3291 (52.2)
Weight, kg (SD) 71.6 (14.9) 75.4 (16.0) 76.7 (16.2) 78.9 (16.5) 80.6 (16.2) 82.6 (16.7) 82.0 (16.7)
Disease duration, years 8.3 (7.1) 8.6 (7.8) 8.8 (7.7) 9.1 (8.1) 8.7 (7.3) 9.3 (7.1) 9.8 (7.4)
BMI, kg/m2 (SD) 27.1 (4.8) 28.5 (5.3) 29.0 (5.5) 29.8 (5.5) 29.6 (5.5) 30.2 (5.7) 29.8 (5.5)
Hypertension, n (%) 6029 (60.9) 10,681 (62.5) 7422 (61.0) 3254 (61.1) 6315 (66.0) 3623 (66.4) 4166 (66.2)
Dyslipidaemia, n (%) 4844 (49.3) 9609 (60.2) 7267 (62.5) 3485 (67.2) 5855 (63.4) 3449 (64.8) 3970 (68.9)
Last HbA1c measurement, mmol/mol (SD) 61.5 (19.5) 63.2 (21.1) 62.3 (21.3) 62.6 (20.2) 64.4 (21.0) 64.1 (19.5) 64.6 (20.7)
Last HbA1c measurement, % (SD) 7.8 (1.8) 7.9 (1.9) 7.9 (2.0) 7.9 (1.9) 8.0 (1.9) 8.0 (1.8) 8.1 (1.9)
HbA1c testing, n (%) 6116 (61.8) 12,492 (76.5) 9217 (80.4) 4401 (85.5) 8399 (90.0) 4952 (92.1) 5719 (92.9)
Frequency of testing of HbA1c during past year 1.6 (1.2) 2.2 (1.4) 2.3 (1.4) 2.2 (1.5) 2.2 (1.8) 2.2 (2.0) 2.2 (1.7)

Mean values are presented unless otherwise stated

Percentages were calculated for patients with available data; these varied by each category/wave

Hypertension and dyslipidaemia were defined (yes/no) according to the attending physician

Footnotes

The online version of the original article can be found at 10.1007/s00125-019-05078-3


Articles from Diabetologia are provided here courtesy of Springer

RESOURCES